Privia Health Group Management
Management criteria checks 2/4
Privia Health Group's CEO is Parth Mehrotra, appointed in Jul 2023, has a tenure of 1.5 years. total yearly compensation is $17.07M, comprised of 3.2% salary and 96.8% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth $3.06M. The average tenure of the management team and the board of directors is 5.6 years and 3.2 years respectively.
Key information
Parth Mehrotra
Chief executive officer
US$17.1m
Total compensation
| CEO salary percentage | 3.2% |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.1% |
| Management average tenure | 5.6yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar
Nov 08
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Nov 04It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)
Sep 12There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings
Aug 16Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jul 12Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity
Jun 11Privia Health: Key Lessons Learned (Rating Downgrade)
May 22Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers
Mar 03The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)
Feb 27There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jan 31Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching
Dec 03Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues
Nov 06Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business
Aug 08Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mar 17Privia Health: In Line For Solid FY22, Hold On Valuation
Sep 15Privia Health Group reports Q2 earnings beat; raises FY22 outlook
Aug 11Privia Health Group Grows But Operating Results Await
Jun 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$13m |
| Jun 30 2024 | n/a | n/a | US$15m |
| Mar 31 2024 | n/a | n/a | US$19m |
| Dec 31 2023 | US$17m | US$542k | US$23m |
| Sep 30 2023 | n/a | n/a | US$38m |
| Jun 30 2023 | n/a | n/a | US$34m |
| Mar 31 2023 | n/a | n/a | US$16m |
| Dec 31 2022 | US$1m | US$475k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$49m |
| Mar 31 2022 | n/a | n/a | -US$211m |
| Dec 31 2021 | US$52m | US$475k | -US$188m |
| Sep 30 2021 | n/a | n/a | -US$172m |
| Jun 30 2021 | n/a | n/a | -US$147m |
| Mar 31 2021 | n/a | n/a | US$31m |
| Dec 31 2020 | US$1m | US$412k | US$31m |
Compensation vs Market: Parth's total compensation ($USD17.07M) is above average for companies of similar size in the US market ($USD5.42M).
Compensation vs Earnings: Parth's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Parth Mehrotra (45 yo)
1.5yrs
Tenure
US$17,073,185
Compensation
Mr. Parth Mehrotra serves as Chief Executive Officer and Director of Privia Health Group, Inc. since July 1, 2023. He had been the President and Chief Operating Officer of Privia Health Group, Inc. since 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$17.07m | 0.13% $ 3.1m | |
| Executive VP | 2.8yrs | US$2.32m | 0.22% $ 5.3m | |
| Chief Operating Officer | less than a year | no data | no data | |
| Executive VP & Chief Technology Officer | 8.8yrs | no data | no data | |
| Senior Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief Audit & Compliance Officer | 5.6yrs | no data | no data | |
| Executive VP | less than a year | no data | no data | |
| Chief People Officer | 8.4yrs | no data | no data | |
| Senior VP & Chief Growth Officer | no data | no data | no data | |
| Executive Vice President of Medical Groups | 8.9yrs | no data | no data | |
| Executive VP & Chief Clinical Officer | 7.2yrs | no data | no data | |
| Chairman of the Board of Governors | no data | no data | no data |
5.6yrs
Average Tenure
Experienced Management: PRVA's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$17.07m | 0.13% $ 3.1m | |
| Independent Director | 2.8yrs | US$275.06k | 0.0059% $ 141.1k | |
| Independent Director | 1.4yrs | US$202.69k | 0.0052% $ 123.6k | |
| Independent Director | 1.5yrs | no data | no data | |
| Independent Director | 3.8yrs | US$290.06k | 0.013% $ 300.1k | |
| Independent Chairman | 4yrs | US$335.06k | 0.013% $ 300.1k | |
| Director | 1.4yrs | US$211.02k | 0.0052% $ 123.6k | |
| Director | 6.7yrs | US$679.52k | 0.045% $ 1.1m | |
| Independent Director | 3.8yrs | US$300.06k | 0.035% $ 828.0k | |
| Independent Director | 3.6yrs | US$275.06k | 0.0095% $ 226.8k |
3.2yrs
Average Tenure
62yo
Average Age
Experienced Board: PRVA's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 05:21 |
| End of Day Share Price | 2025/01/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Privia Health Group, Inc. is covered by 31 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| Adam Ron | BofA Global Research |